MABp1 IN HIDRADENITIS SUPPURATIVA REFRACTORY TO ADALIMUMAB
Clinical trial NCT02643654 · COMPLETED
Trial details
- NCT number
- NCT02643654
- Sponsor
- Evangelos J. Giamarellos-Bourboulis, M.D.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2016-10-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.